ODDB.org: Open Drug Database

Swissmedic Registration	49749	Date of registration	28.12.1993
Company name	GlaxoSmithKline AG	Revision date	05.11.2007
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	08.05.10.	Revocation Date
Index Therapeuticus (Swissmedic)	08.05.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
03	Zentel	Suspension zum Einnehmen	Suspension (oral) (Albendazole 400mg / 10ml)	P02CA03	CI

2025	©ywesee GmbH